Chemical Namebenznidazole
Dosage FormTablet (oral; 12.5 mg, 100 mg)
Drug ClassAntiprotozoal
SystemBlood, Digestive, Cardiovascular, Nervous
CompanyChemo Research Sl
Approval Year2017


  • Benznidazole is indicated in pediatric patients 2 to 12 years of age for the treatment of Chagas disease (American trypanosomiasis), caused by Trypanosoma cruzi.
Last updated on 2/3/2021

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Benznidazole (benznidazole) prescribing information.2017Exeltis
Document TitleYearSource
Ideal benznidazole dose regimen in chronic chagasic patients: a systematic review.2020Journal of the Sao Paulo Institute of Tropical Medicine
Trypanocidal drugs for lateā€stage, symptomatic Chagas disease (Trypanosoma cruzi infection)2020Cochrane Database of Systematic Reviews
Document TitleYearSource
Guidelines for the diagnosis and treatment of Chagas disease.2019WHO-Pan American Health Organization - WHO